Evidence map›Paper›PMID 36942117›Full record

ArticleAsian journal of urology2023

Role of circulating tumor cell clusters in patients with metastatic hormone-sensitive prostate cancer receiving a gonadotropin-releasing hormone antagonist: A pilot study.

Yuki Kohada, Hiroki Kusumoto, Takashi Kukimoto, Jotaro Mikami, Jun Ito, Katsutoshi Asano, Toru Yaegashi, Kanichi Nakagawara, Jun Teishima, Yasuhiro Kaiho and 3 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Asian journal of urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Yuki KohadaDivision of Urology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Hiroki KusumotoDivision of Urology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Takashi KukimotoDivision of Urology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Jotaro MikamiDivision of Urology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Jun ItoDivision of Urology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Katsutoshi AsanoNihon Gene Research Laboratories Inc, Sendai, Japan.
Toru YaegashiNihon Gene Research Laboratories Inc, Sendai, Japan.
Kanichi NakagawaraNihon Gene Research Laboratories Inc, Sendai, Japan.
Jun TeishimaDepartment of Urology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.
Yasuhiro KaihoDivision of Urology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Nobuyuki HinataDepartment of Urology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.
Yasuhiro NakamuraDivision of Pathology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Makoto SatoDivision of Urology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Tohoku Medical and Pharmaceutical University · JPHiroshima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36942117
PMCPMC10023524
OpenAlexW4286435966

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.